Digg It - Internet and Businesses Online

If MSN® adCenter has an Achilles' heel, it’s on the back end. While this new pay-per-click, or PPC, advertising platform has some

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

innovative targeting and analytic features, search marketers find using them can be messy.

While adCenter supports a simple camp

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

aign well enough, difficulties arise when search-engine marketers, or SEM's, try to simultaneously manage complex, high-volume cam

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

paigns for their clients. For instance, adCenter ads and keywords must be set up separately and individually. Uploading the same d

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ta with Google™ and Yahoo!® can be accomplished by uploading a single spreadsheet. The additional set-up time adds considerable co

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

st to managing an adCenter campaign and increases the chance for errors.

When errors occur, fixing them is a challenge, due to cr

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

eaky adCenter customer support. Among the complaints registered by advertisers are:

-- difficulty finding a knowledgeable se

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

vice representative;
-- slow response once contact is made;
-- form letter e-mail responses that do not really help;

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

-- lengthy processing time for standard tracking reports;
-- confusing or incorrect data on tracking reports;
-- progr

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

amming glitches that bring campaigns to a temporary standstill; and,
-- no way to manage multiple accounts with one global lo

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

in.

To a degree, some problems can be excused by adCenter's novelty. This paid-search option is very much a work-in-progress.

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

Microsoft® took the platform out of beta in May 2006, and has been upgrading and adding features ever since. Rapid, ongoing deve

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

lopment is unavoidable if adCenter wants to keep pace with market leader Google® AdSense. Even an industry giant like Microsoft® c

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

annot be expected to perfect programming and support within a few months under these circumstances.

Other problems stem from corp

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

rate gamesmanship. Initially, adCenter did not support the Firefox® 1.5 browser. However, since at least 20 percent of the market

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

uses Firefox®, adCenter’s move rendered SEM’s incapable of tracking conversions on large chunks of their PPC campaigns. Finally, i

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

n early August, Microsoft® upgraded adCenter to work with the open-source browser, but by then, the damage to advertiser confidenc

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

already was done.

Given Microsoft®’s track record, it is hard to imagine adCenter’s back-end pain lasting for long. Whether toda

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

y’s headaches turn SEM’s away from the platform long-term remains to be seen. However, as Microsoft® and Google™ continue to advan

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ce on each other’s turf with products outside their core strengths, users everywhere will have to live with a lot of growing pains

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/72723/diggit-Troubles-on-the-Back-End.html">Troubles on the Back End</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/72723/diggit-Troubles-on-the-Back-End.html]Troubles on the Back End[/url]

Although many of the best-known catalogues come from large companies, the mail-order business presents incredible opportunities for small businesses with the right blend of products, marketing strategies, prices and target customers. To compete successfully the entrepreneur must target a specific market. What does it take to succeed in the highly competitive mail-order industry?

People see, hear, then they believe. Whatever the purpose of your speaking, it is ultimately important that the audience believes you. Your credibility is vital before they will buy your product, service, or your call to action.

Are you really telling me you only use Google Adwords for your pay per click advertising? If you're ignoring pay per click advertising on Yahoo you could be loosing some serious profits.

Tags

Links

Digg It - Troubles on the Back End

Related Articles: